Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Category | Mid Cap | Mid Cap |
| Plan | Direct | Direct |
| Fund house | Mirae Asset | Nippon India |
| NAV | ₹43.2340 | ₹4,949.4053 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 7.3 years | 13.9 years |
| Expense ratio | 0.9% | 0.8% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 36.60 | 65.70 |
Returns
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| 1 month | +5.39% | +5.45% |
| 3 months | −2.87% | −2.03% |
| 6 months | +4.34% | +2.57% |
| YTD | +4.28% | +6.56% |
| 1 year | +4.24% | +5.19% |
| 3 years (CAGR) | +15.11% | +16.47% |
| 5 years (CAGR) | +14.32% | +17.01% |
| 10 years (CAGR) | — | +19.06% |
| Since launch | +22.29% | +17.82% |
Risk
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Volatility | 18.7% | 17.9% |
| Downside volatility | 12.8% | 11.7% |
| Sharpe | 0.46 | 0.56 |
| Sortino | 0.68 | 0.85 |
| Calmar | 0.67 | 0.83 |
| Return / risk | 0.81 | 0.92 |
| Deepest fall | −37.38% | −35.32% |
| Days to recover | 213 | 224 |
| Below its high | −4.17% | −2.58% |
Against benchmark
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Alpha | +1.21% | +2.40% |
| Beta | 1.01 | 0.96 |
| R² | 97.5% | 95.9% |
| Up capture | 104.0% | 100.8% |
| Down capture | 100.1% | 90.2% |
| Tracking error | 2.9% | 3.7% |
| Information ratio | 0.43 | 0.56 |
| Treynor | 0.08 | 0.09 |
Consistency
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Best 1-year | +119.63% | +96.36% |
| Middle 1-year | +17.94% | +15.30% |
| Worst 1-year | −4.31% | −27.61% |
| 1-year periods with a loss | 3.7% | 13.6% |
| Middle 3-year | +23.44% | +21.76% |
| Positive months | 66.7% | 69.4% |
| Best day | +3.90% | +4.57% |
| Worst day | −6.40% | −7.42% |
| Worst 5% day | −1.86% | −1.82% |
| Positive days | 57.2% | 54.9% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| 5-year XIRR | +15.07% | +17.42% |
| 5-year value | ₹8,81,436 | ₹9,34,974 |
| 3-year XIRR | +10.17% | +10.20% |
| 1-year XIRR | +8.47% | +8.03% |
Holdings overlap i
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Mirae Asset Midcap Fund | — | 30% |
| Nippon India Growth Mid Cap Fund | 30% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund |
|---|---|---|
| The Federal Bank Limited | 3.30% | 2.85% |
| BSE Limited | 2.23% | 2.73% |
| Persistent Systems Limited | 3.17% | 2.03% |
| One 97 Communications Limited | 1.89% | 2.37% |
| Bharat Forge Limited | 2.43% | 1.79% |
| Mankind Pharma Limited | 1.65% | 1.99% |
| Gland Pharma Limited | 1.55% | 1.77% |
| Voltas Limited | 2.34% | 1.49% |
| Bharat Heavy Electricals Limited | 1.50% | 1.35% |
| FSN E-Commerce Ventures Limited | 1.52% | 1.20% |
| Prestige Estates Projects Limited | 2.26% | 1.11% |
| Indian Bank | 2.05% | 1.08% |
| Dixon Technologies (India) Limited | 2.54% | 0.94% |
| Ge Vernova T&D India Limited | 0.92% | 1.97% |
| Lupin Limited | 3.43% | 0.90% |
| Swiggy Limited | 1.50% | 0.87% |
| Max Financial Services Limited | 0.79% | 1.20% |
| HDB Financial Services Limited | 2.19% | 0.72% |
| Multi Commodity Exchange of India Limited | 0.68% | 3.20% |
| Schaeffler India Limited | 1.11% | 0.66% |
| Vishal Mega Mart Limited | 1.52% | 0.60% |
| Gujarat Fluorochemicals Limited | 0.74% | 0.53% |
| Dalmia Bharat Limited | 1.88% | 0.47% |
| Container Corporation Of India Limited | 1.39% | 0.44% |
| 3M India Limited | 1.30% | 0.36% |
Sectors and company size
| Mirae Asset Midcap Fund | Nippon India Growth Mid Cap Fund | |
|---|---|---|
| Large companies | 12.7% | 22.4% |
| Mid companies | 68.0% | 66.0% |
| Small companies | 15.6% | 11.5% |
| Top 10 holdings | 32.3% | 25.7% |
| Largest sector | Pharmaceuticals & Biotechnology 12% | Banks 10% |